8:45am ET
Health and Healthcare
Why Have Short Sellers Backed Off Major Biotechs?
The July 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Companies
Celgene
$108.24
▲ $0.00 (+0.00%) today
Markets closed · 10:34pm ET
CELG Coverage
Page 410:40am ET
Health and Healthcare
Should Celgene Be Getting More Love?
Celgene released better-than-expected quarterly results and updated guidance before the markets opened on Thursday.
Chris Lange 7:10am ET
Health and Healthcare
Major Biotechs See a Rising Tide of Short Interest
The July 13 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
10:25am ET
Health and Healthcare
Amgen, Eli Lilly, Gilead and More Major Health Care Companies Reporting This Week
24/7 Wall St. has put together a preview of AbbVie, Eli Lilly, Gilead Sciences and some of the other, larger health care companies that are about to report their quarterly results.
10:30am ET
Health and Healthcare
Will Acceleron Pharma Momentum Continue After New FDA Nod?
Acceleron Pharma shares dipped on Friday after the company provided an update on an orphan drug designation from the FDA.
Chris Lange 8:21am ET
Health and Healthcare
Short Sellers Back Off Major Biotechs
The June 29 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
9:45am ET
Health and Healthcare
Celgene and Acceleron Pharma Win Again in Late-Stage Trial
Acceleron Pharma and Celgene each saw a handy gain on Tuesday morning after it was announced results from their late-stage study in adults with transfusion-dependent beta-thalassemia.
Chris Lange 8:15am ET
Health and Healthcare
Massive Biopharma Movers of the Past Week
A few biopharma stocks made massive runs over the course of this past week, some losing more than half their cap. Not all these moves were negative, but the overall sentiment was…
Chris Lange 11:05am ET
Health and Healthcare
Acceleron Pharma and Celgene Knock It Out of the Park in Late-Stage Trial
Acceleron Pharma and Celgene each saw gains on Friday after they reported results from a late-stage trial.
Chris Lange 9:00am ET
Health and Healthcare
Short Sellers Run for Cover From Major Biotechs
The June 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
10:54am ET
Health and Healthcare
Short Sellers Up the Ante For Major Biotechs
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The May 31 short interest data have been compared with the previous report, and short interest moves in…
9:30am ET
Investing
The 6 Most Shorted Nasdaq Stocks
The two most-shorted Nasdaq stocks held onto their positions in the short-interest reporting period that ended on May 31. There was one big mover in an otherwise mostly calm two weeks.
10:30am ET
Health and Healthcare
Biotech and Pharmaceutical Giants Go All In With Big Data Analytics
It’s no surprise that it was only a matter of time before the usage and storage of big data and analytics would come to the health care sector, and many of the…
9:40am ET
Health and Healthcare
Short Interest Remains Mixed in Major Biotechs
The May 15 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
8:50am ET
Investing
Top Analyst Upgrades and Downgrades: Celgene, Cypress Semi, Intuit, KemPharm, Oasis Petroleum, Rio Tinto, Shake Shack and More
The top analyst upgrades, downgrades and other research calls from Wednesday include Celgene, Cypress Semiconductor, Intuit, KemPharm, Oasis Petroleum, Rio Tinto and Shake Shack.
